RET 유전자의 G691S 단일염기다형성을 동반한 갑상선 수질암 = A Case of Sporadic Medullary Thyroid Cancer with RET G691S Polymorphism

다국어 초록 (Multilingual Abstract)

Sporadic medullary thyroid carcinoma (MTC) is the most common form of MTC and somatic RET proto-oncogene mutations account for approximately 25% of the patients with sporadic MTC. However, other pathogeneses of sporadic MTC are still unclear. Not only RET mutation, but also polymorphisms of RET may have an association with sporadic MTC. We herein describe the association of MTC and RET proto-oncogene polymorphism. A 51-year-old man was diagnosed with MTC, which was incidentally found on a thyroid sonogram. The patient underwent total thyroidectomy and genetic mutational analysis of the RET gene. Genetic testing detected a polymorphism in codon 691 (G691S) on exon 11 of the RET proto-oncogene. His son and daughter had the same polymorphism. We report on this case along with a review of the related literature on RET gene polymorphism of sporadic MTC.

참고문헌 (Reference)

1 김형훈, "한국인 갑상선 수질암 환자에서 RET 원종양유전자 점돌연변이 양상" 대한내분비학회 18 (18): 360-370, 2003

2 Weinhaeusel A, "The influence of gender, age, and RET polymorphisms on C-cell hyperplasia and medullary thyroid carcinoma" 18 : 1269-1276, 2008

3 Sawai H, "The G691S RET polymorphism increases glial cell line-derived neurotrophic factor-induced pancreatic cancer cell invasion by amplifying mitogen-activated protein kinase signaling" 65 : 11536-11544, 2005

4 Gursoy A, "Significance of the RET proto-oncogene polymorphisms in Turkish sporadic medullary thyroid carcinoma patients" 29 : 858-862, 2006

5 Wohllk N, "Relevance of RET proto-oncogene mutations in sporadic medullary thyroid carcinoma" 81 : 3740-3745, 1996

6 윤승욱, "RET 유전자의 C634R 돌연변이 및 G691S 단일염기다형성을 동반한 제2A형 다발성 내분비선종 가계" 대한내분비학회 22 (22): 453-459, 2007

7 Fugazzola L, "RET genotypes in sporadic medullary thyroid cancer: studies in a large Italian series" 69 : 418-425, 2008

8 Elisei R, "RET exon 11 (G691S) polymorphism is significantly more frequent in sporadic medullary thyroid carcinoma than in the general population" 89 : 3579-3584, 2004

9 Schilling T, "Prognostic value of codon 918 (ATG->ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma" 95 : 62-66, 2001

10 Cebrian A, "Polymorphisms in the initiators of RET (rearranged during transfection) signaling pathway and susceptibility to sporadic medullary thyroid carcinoma" 90 : 6268-6274, 2005

11 Robledo M, "Polymorphisms G691S/S904S of RET as genetic modifiers of MEN 2A" 63 : 1814-1817, 2003

12 Uchino S, "Novel point mutations and allele loss at the RET locus in sporadic medullary thyroid carcinomas" 89 : 411-418, 1998

13 Jimenez C, "Management of medullary thyroid carcinoma" 37 : 481-496, 2008

14 Cardot-Bauters C, "Groupe d'Etude des Tumeurs Endocrines (GTE): Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?" 69 : 506-510, 2008

15 Ruiz A, "Germline sequence variant S836S in the RET proto-oncogene is associated with low level predisposition to sporadic medullary thyroid carcinoma in the Spanish population" 55 : 399-402, 2001

16 Wohllk G N, "G691S, L769L and S836S ret proto-oncogene polymorphisms are not associated with higher risk to sporadic medullary thyroid carcinoma in Chilean patients" 133 : 397-402, 2005

17 Fernandez RM, "Analysis of RET polymorphisms and haplotypes in the context of sporadic medullary thyroid carcinoma" 16 : 411-417, 2006

18 Borrego S, "A founding locus within the RET proto-oncogene may account for a large proportion of apparently sporadic Hirschprung disease and a subset of cases of sporadic medullary thyroid carcinoma" 72 : 88-100, 2003